August 27, 2012 Issue | Chemical & Engineering News
Copyright © 2012 American Chemical Society

August 27, 2012 Issue

Volume 90, Issue 35
August 27, 2012 Issue, Vol. 90 | Iss. 35
Scientific instrument makers bolster positions in the growing market for human clinical health testing
By Marc S. Reisch
(pp. 14-18)
Italian firms are investing aggressively in R&D and building plants to make chemicals from renewable feedstocks (pp. 22-24)
Science & Technology
How an academic pursuit to understand epoxomicin became the cancer treatment carfilzomib (pp. 34-35)
Back Issues

News of the Week

American Chemical Society Holds National Meeting In Philadelphia

ACS Meeting News: 'Materials for Health & Medicine' was meeting's theme

BASF Joins Cargill And Novozymes On Process For Biobased Acrylic Acid

Initial plan is to use acrylic acid to manufacture superabsorbent polymers

Court Upholds Gene Patents

Biotechnology: Appeals court finds that isolated DNA is eligible for patent protection

Glycosylation Linked To Cancer

ACS Meeting News: Enzyme modification may be a control point that can be exploited to fight cancer

Mouse Model Shows How Antibiotic Use In Early Life Leads To Weight Gain

Microbiome: Study shows subtherapeutic antibiotic use affects gut microbial communities

Air Pollution Rule Struck Down

Clean Air: Court says EPA went too far with rule to reduce emissions that cross state lines

Organocatalyst Splits Water

ACS Meeting News: Flavinium ion is first nonmetal catalyst to generate O2 during electrolysis

German TV Crew Mobbed In China

Police rescued reporters who were filming about industrial pollution

Tracking Nanoparticle Growth

Synthesis: Labeling method sheds light on how nanoparticles take shape

Oxy And Mexichem Join For Ethylene

Petrochemicals: Companies envision tapping into shale gas with a new cracker

Toward Better Ferroelectrics

ACS Meeting News: Organic material switches polarization at room temperature



Government & Policy

Euroscience Open Forum spotlights science on the European agenda, including the role of science in economic and cultural life
(pp. 30-31)
Synthetic marijuana compounds, two stimulants, and nine hallucinogens are outlawed in U.S.
(pp. 28-29)

Science & Technology

Consultant relishes bridge-building between teams researching new types of Alzheimer’s drugs
IUPAC effort sets parameters for structural interaction seen in materials science and biology
How an academic pursuit to understand epoxomicin became the cancer treatment carfilzomib
(pp. 34-35)